Hypertension-related target organ damage: Is it a continuum?

Journal of Hypertension

Volumn 31, Issue 6, 2013, Pages 1083-1085

  Perlini, Stefano ^a   Grassi, Guido ^b,c  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; ELECTROCARDIOGRAM; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NOTE; ORGAN INJURY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULSE PRESSURE; TARGET ORGAN; WHITE COAT HYPERTENSION;

EID: 84877259014     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836157da     Document Type: Note

References (24)

1. Pickering G. The nature of essential hypertension: J & A. Churchill Ltd; 1961.
2. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
4. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
5. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345:1291-1297.
6. Perlini S, Naditch-Brule L, Farsang C, Zidek W, Kjeldsen SE. Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from theGOODsurvey. J HumHypertens 2012 Dec 13. doi: 10.1038/jhh.2012.61. [Epub ahead of print]
7. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; 2:695-698.
8. Laurent S, Alivon M, Beaussier H, Boutouyrie P. Aortic stiffness as a tissue biomarker for predicting future cardiovascular events in asymptomatic hypertensive subjects. Ann Med 2012; 44 (Suppl 1):S93-S97.
9. Matsui Y, Ishikawa J, Shibasaki S, Shimada K, Kario K. Association between home arterial stiffness index and target organ damage in hypertension: comparison with pulse wave velocity and augmentation index. Atherosclerosis 2011; 219:637-642.
10. Garcia-Garcia A, Gomez-Marcos MA, Recio-Rodriguez JI, Patino-Alonso MC, Rodriguez-Sanchez E, Agudo-Conde C, et al. Office and 24-h heart rate and target organ damage in hypertensive patients. BMC Cardiovasc Disord 2012; 12:19.
11. Grassi G. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 2010; 23:1052-1060.
12. Falcao-Pires I, Palladini G, Goncalves N, van der Velden J, Moreira-Goncalves D, Miranda-Silva D, et al. Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol 2011; 106:801-814.
13. Tozzi R, Palladini G, Fallarini S, Nano R, Gatti C, Presotto C, et al. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypertens 2007; 20:663-669.
14. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
15. Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens 2012; 30:1289-1299.
16. Hänninen M-R, Niiranen TJ, Puukka PJ, Kesäniemi YA, Kähönen M, Jula AM. Target organ damage and masked hypertension in the general population: the Finn-Home study. J Hypertens 2013; 31:1136-1143.
17. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969; 71:89-105.
18. Perlini S, Chung ES, Aurigemma GP, Meyer TE. Alterations in early filling dynamics predict the progression of compensated pressure overload hypertrophy to heart failure better than abnormalities in midwall systolic shortening. Clin Exp Hypertens 2012. [Epub ahead of print]
19. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69:107-115.
20. Vatner SF, Shannon R, Hittinger L. Reduced subendocardial coronary reserve. A potential mechanism for impaired diastolic function in the hypertrophiedandfailingheart.Circulation1990;81(2Suppl):III8-III14.
21. Muiesan ML, de Simone G, Ganau A, Longhini C, Verdecchia P, Mancia G, et al. Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients. J Hypertens 2006; 24:2293-2298.
22. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115:459-467.
23. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318-1327.
24. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 29:1880-1888.